Charles Elliott Sigal - May 21, 2021 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
Director
Signature
/s/ Howard Horn, Attorney-in-Fact
Stock symbol
VIR
Transactions as of
May 21, 2021
Transactions value $
$0
Form type
4
Date filed
5/25/2021, 04:48 PM
Next filing
Jun 10, 2021
SEC
View on sec.gov

Transactions Table

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIR Stock Option (Right to Buy) Award $0 +6.75K $0.00 6.75K May 21, 2021 Common Stock 6.75K $45.28 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.